Nec Corporation

Tokyo Medical University

Masami Tanaka

Masahiko Kuroda

Masakatsu Takanashi

Kosuke Oikawa

Yoshinori Kosugi

Takayuki Mizutani

Seiko Iizuka

Kazuma Ohyashiki

Akihiko Tsuchida

Masataka Nagasawa

The present invention provides a novel cancer marker for evaluating the onset, the preclinical stage, the clinical stage, or the prognosis of a cancer in a subject, and an evaluation method using the same. A cancer marker containing at least one miRNA selected from hsa-miR-92 and hsa-miR-494 is used as a marker for cancers excluding breast cancer. A method for evaluating the possibility of cancers excluding breast cancer includes the step of detecting the expression level of a cancer marker in a biological sample collected from a subject. In this method, the cancer marker contains at least one miRNA selected from hsa-miR-92 and hsa-miR-494.

Cancer marker, method for evaluation of cancer by using the cancer marker, and evaluation reagent

In an apparatus for marking a high point mark on a sidewall of tire at a peak position of a primary waveform of RFV of the tire, the position of tire to be stopped is controlled by an AC servo controller, so that the process of marking can be effected preciously and speedy.

Apparatus for marking high point mark on tire

Growing community of inventors

Fukuoka, Japan

Masami Tanaka